Literature DB >> 17465484

Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.

Shi-Ying Xuan1, Yong-Ning Xin, Hua Chen, Guang-Jun Shi, Hua-Shi Guan, Yang Li.   

Abstract

AIM: To investigate the correlation between hepatitis B virus surface antigen (HBsAg), hepatitis C virus (HCV) expression in hepatocellular carcinoma (HCC), the HAI score of the noncancerous region of the liver and the serum Alpha fetoprotein (AFP) level.
METHODS: The patterns of HBsAg and HCV in 100 cases of HCC and their surrounding liver tissues were studied on paraffin-embedded sections with immuno-histochemistry, the histological status was determined by one pathologist and one surgeon simultaneously using the hepatitis activity index (HAI) score, and AFP was detected by radioimmunity. The study included 100 consecutive patients who underwent curative resection for HCC. Based on HBsAg and HCV expression, the patients were classified into 4 groups: patients positive for HBsAg (HBsAg group), patients positive for HCV (HCV group), patients negative for both HCV and HBsAg (NBNC group) and patients positive for both HBsAg and HCV (BC group).
RESULTS: The BC group had significantly higher HAI scores than the other three groups. (BC > HCV > HBsAg > NBNC). HBV and HCV virus infection was positively correlated with HAI (r(s) = 0.39, P = 0.0001). The positive rate of AFP (85.7%) and the value of AFP (541.2 ng/mL) in the group with HBV and HCV co-infection were the highest among the four groups. The positive rate (53.3%) of AFP and the value of AFP ( 53.3 ng/mL) in the group with none-infection of HBV and HCV were the lowest. HBV and HCV virus infection was positively correlated with AFP(r(s) = 0.38, P = 0.0001).
CONCLUSION: The AFP increase in patients with liver cancer was positively correlated with the infection of HBV and HCV. The serum AFP elevation by the infection of HBV and HCV is one of mechanisms which lead to hepatocarcinogenesis, and the antivirus intervening treatment of hepatitis is significant for the prognosis of liver cancer. From our Spearman's rank correlation analysis, we can conclude that the severity of virally induced inflammation is correlated with HBsAg and HCV expression in HCC tissues and noncancerous tissues. Prior co-infection of HBV in HCV patients may be an adverse risk factor for intrahepatic inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465484      PMCID: PMC4149970          DOI: 10.3748/wjg.v13.i12.1870

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis.

Authors:  S Ueno; G Tanabe; A Yoshida; S Yoshidome; S Takao; T Aikou
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

2.  Immunohistochemical detection of HCV infection in patients with hepatocellular carcinoma and other liver diseases.

Authors:  Li-Fa Zhang; Wen-Wei Peng; Ji-Lu Yao; Yong-Huang Tang
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

3.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

Review 4.  Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

Authors:  Valeer J Desmet
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

5.  Helicobacter infection in hepatocellular carcinoma tissue.

Authors:  Shi-Ying Xuan; Ning Li; Xin Qiang; Rong-Rong Zhou; Yong-Xin Shi; Wen-Jie Jiang
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

6.  Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Gibo; K Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; R H Purcell
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

7.  A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.

Authors:  F Donato; P Boffetta; M Puoti
Journal:  Int J Cancer       Date:  1998-01-30       Impact factor: 7.396

8.  Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro.

Authors:  X W Wang; H Xie
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 9.  Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.

Authors:  W H Caselmann; M Alt
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

10.  Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.

Authors:  Y F Liaw; D I Tai; C M Chu; D Y Lin; I S Sheen; T J Chen; C C Pao
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

View more
  1 in total

Review 1.  Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Authors:  Gar-Yang Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.